Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
DMT-310 by Dermata Therapeutics for Psoriasis: Likelihood of Approval
DMT-310 is under clinical development by Dermata Therapeutics and currently in Phase I for Psoriasis. According to GlobalData, Phase I...
Data Insights
DMT-310 by Dermata Therapeutics for Acne Vulgaris: Likelihood of Approval
DMT-310 is under clinical development by Dermata Therapeutics and currently in Phase III for Acne Vulgaris. According to GlobalData, Phase...